TY - JOUR
T1 - Transcutaneous blood gas monitoring among neonatal intensive care units in Japan
AU - Ochiai, Masayuki
AU - Kurata, Hiroaki
AU - Inoue, Hirosuke
AU - Ichiyama, Masako
AU - Fujiyoshi, Junko
AU - Watabe, Shinichi
AU - Hiroma, Takehiko
AU - Nakamura, Tomohiko
AU - Ohga, Shouichi
N1 - Funding Information:
This study was supported in part by JSPS KAKENHI Grant Number JP17K16300 (HI) and JP16K19688 (JF). The authors acknowledge Ms Arikawa Miho for the data collection and analysis, Ms Ingu Asumi, Ms Nagano Kahori, and Ms Ueno Fujimi, the nursing staff for the design of the questionnaire.
Funding Information:
This study was supported in part by JSPS KAKENHI Grant Number JP17K16300 (HI) and JP16K19688 (JF). The authors acknowledge Ms Arikawa Miho for the data collection and analysis, Ms Ingu Asumi, Ms Nagano Kahori, and Ms Ueno Fujimi, the nursing staff for the design of the questionnaire.
Publisher Copyright:
© 2019 Japan Pediatric Society
PY - 2020/2/1
Y1 - 2020/2/1
N2 - Background: This study aimed to investigate the utility of transcutaneous (tc) measurements of partial pressure of oxygen (tcPO2) and carbon dioxide (tcPCO2) monitoring in neonatal intensive care units (NICUs) in Japan. Methods: At the end of 2016,we sent a survey questionnaire on tc monitoring to all 106 NICUs registered with the Japanese Neonatologist Association. The questions included usage, subjects, methods, management, and the practical usefulness of tc monitoring. Results: The questionnaire was returned by 69 NICUs (65.1% of response rate). Seventeen institutions (24.6%) measured both tcPCO2 and tcPO2, and 42 (60.9%) measured tcPCO2 alone. Transcutaneous PCO2 or tcPO2 monitoring was applied for “pre-viable” infants born at 22–23 weeks’ gestational age (18.6% vs 23.5%), and infants of <500 g birthweight (30.5% vs 17.6%). The tcPCO2 and tcPO2 monitoring was started at birth in 49.2% and 70.6% of the newborn infants, respectively. The temperature of the sensor was set at <38°C for tcPCO2 in 54.3% and >42°C for tcPO2 in 58.9% of NICUs. The accuracy for tcPO2 was rated as good in 35.3% or moderate in 64.7%, of institutions but or for tcPCO2 as 1.7% or 93.2%of institutions, respectively. Conclusion: Transcutaneous monitoring was widely, but limitedly, used for preterm infants. The lower temperature of the tcPCO2 sensor compared to that reported in other developed countries might compromise the accuracy but increase the feasibility of tc monitoring in Japan.
AB - Background: This study aimed to investigate the utility of transcutaneous (tc) measurements of partial pressure of oxygen (tcPO2) and carbon dioxide (tcPCO2) monitoring in neonatal intensive care units (NICUs) in Japan. Methods: At the end of 2016,we sent a survey questionnaire on tc monitoring to all 106 NICUs registered with the Japanese Neonatologist Association. The questions included usage, subjects, methods, management, and the practical usefulness of tc monitoring. Results: The questionnaire was returned by 69 NICUs (65.1% of response rate). Seventeen institutions (24.6%) measured both tcPCO2 and tcPO2, and 42 (60.9%) measured tcPCO2 alone. Transcutaneous PCO2 or tcPO2 monitoring was applied for “pre-viable” infants born at 22–23 weeks’ gestational age (18.6% vs 23.5%), and infants of <500 g birthweight (30.5% vs 17.6%). The tcPCO2 and tcPO2 monitoring was started at birth in 49.2% and 70.6% of the newborn infants, respectively. The temperature of the sensor was set at <38°C for tcPCO2 in 54.3% and >42°C for tcPO2 in 58.9% of NICUs. The accuracy for tcPO2 was rated as good in 35.3% or moderate in 64.7%, of institutions but or for tcPCO2 as 1.7% or 93.2%of institutions, respectively. Conclusion: Transcutaneous monitoring was widely, but limitedly, used for preterm infants. The lower temperature of the tcPCO2 sensor compared to that reported in other developed countries might compromise the accuracy but increase the feasibility of tc monitoring in Japan.
UR - http://www.scopus.com/inward/record.url?scp=85079720176&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85079720176&partnerID=8YFLogxK
U2 - 10.1111/ped.14107
DO - 10.1111/ped.14107
M3 - Article
C2 - 31845473
AN - SCOPUS:85079720176
SN - 1328-8067
VL - 62
SP - 169
EP - 174
JO - Pediatrics International
JF - Pediatrics International
IS - 2
ER -